Evidence map›Paper›PMID 42778850›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Yarrowia lipolytica and Komagataella phaffii (Pichia pastoris) as Hosts for Heterologous Expression of Lipases.

David A Torres-Añorve, Nuria Bernat Camps, Xavier García-Ortega, Francisco Valero, Georgina Sandoval

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David A Torres-AñorveLIBBA Laboratory, Industrial Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco A.C., (CIATEJ), Guadalajara, Jalisco, Mexico. ibq.dtorres@gmail.com.ORCID http://orcid.org/0000-0002-1815-0133
Nuria Bernat CampsDepartment of Chemical, Biological and Environmental Engineering, School of Engineering, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7268-2678
Xavier García-OrtegaDepartment of Chemical, Biological and Environmental Engineering, School of Engineering, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7833-3655
Francisco ValeroDepartment of Chemical, Biological and Environmental Engineering, School of Engineering, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0429-9620
Georgina SandovalLIBBA Laboratory, Industrial Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco A.C., (CIATEJ), Guadalajara, Jalisco, Mexico.ORCID http://orcid.org/0000-0002-9105-0702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The market for industrial lipases is growing due to their wide range of applications. To produce these recombinant enzymes to increase the productivity of the bioprocess, various cell factories, including yeast, have been selected. In the last two decades, the study and improvement of two nonconventional yeasts: K. phaffii and Y. lipolytica as cell factories for heterologous lipase production have increased. However, it is important to consider their differences when choosing between the two cell factories. This chapter compares the characteristics of these yeasts and explores options for enhancing the expression of heterologous lipases at both the molecular and bioprocess levels.

Indexed as

LipaseSaccharomycetalesYarrowiaGene ExpressionRecombinant ProteinsLipaseRecombinant ProteinsCell factoryHeterologous lipaseKomogataella phaffiiPichia pastorisYarrowia lipolytica

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.